SLN · NASDAQ · Biotechnology

Silence Therapeutics (ADR) (SLN)

Develops liver-targeted siRNA medicines through its mRNAi GOLD platform.

$12.29
After hours0.00 (0.00%)
At close$12.29(+0.33%)